AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cambium Bio Limited

0.480

0.000

Volume:- -

Turnover:1.74K

Market Cap:11.02M

PE:-320.00

High:0.480

Open:0.480

Low:0.480

Close:0.480

52wk High:0.640

52wk Low:0.190

Shares:22.97M

Float Shares:4.29M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.001

EPS(LYR):-0.006

ROE:--

ROA:--

PB:--

PE(LYR):-87.21

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Cambium Bio Ltd-Change of Directors Interest Notice - TW

THOMSON REUTERS

Cambium Bio Ltd-Change of Directors Interest Notice - Ew

THOMSON REUTERS

BRIEF-Cambium Bio Signs MoU With Locus Cell For Manufacturing Of Elate Ocular

Cambium Bio Executes Agreement for Contract Manufacturing of Active Biologic Ingredient for Therapy Candidate

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CMB.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CMB.AU\",,,,,undefined,":{"symbol":"CMB.AU","market":"AU","secType":"STK","nameCN":"Cambium Bio Limited","latestPrice":0.48,"timestamp":1766018132238,"preClose":0.48,"halted":0,"volume":0,"delay":0,"nameEN":"Cambium Bio Limited","floatShares":4291164,"shares":22968281,"eps":-0.0015,"marketStatus":"Trading","change":0,"latestTime":"12-18 11:35:32 AEDT","open":0.48,"high":0.48,"low":0.48,"amount":1744.8,"amplitude":0,"askPrice":0.48,"askSize":315,"bidPrice":0.475,"bidSize":1586,"shortable":3,"etf":0,"ttmEps":-0.0015,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766034000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.48,"openAndCloseTimeList":[[1766012400000,1766034000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CMB.AU\",,,,,undefined,":{"symbol":"CMB.AU","floatShares":4291164,"roa":"--","roe":"--","lyrEps":-0.005504,"shares":22968281,"dividePrice":0,"high":0.48,"amplitude":0,"preClose":0.48,"low":0.48,"week52Low":0.19,"pbRate":"--","week52High":0.64,"institutionHeld":0,"latestPrice":0.48,"committee":0.668595,"eps":-0.0015,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0015,"open":0.48,"prevYearClose":0.4,"prevWeekClose":0.48,"prevMonthClose":0.505,"prevQuarterClose":0.52,"fiveDayClose":0.475,"twentyDayClose":0.51,"sixtyDayClose":0.52},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMB.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-07-04","symbol":"CMB.AU","defaultRemindTime":1720051200000,"type":"split","dateTimestamp":1720015200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMB.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2577153495","title":"Cambium Bio Ltd-Change of Directors Interest Notice - TW","url":"https://stock-news.laohu8.com/highlight/detail?id=2577153495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577153495?lang=en_us&edition=fundamental","pubTime":"2025-10-24 05:18","pubTimestamp":1761254302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUE5V61DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMB.AU","BK7067"],"gpt_icon":0},{"id":"2577534952","title":"Cambium Bio Ltd-Change of Directors Interest Notice - Ew","url":"https://stock-news.laohu8.com/highlight/detail?id=2577534952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577534952?lang=en_us&edition=fundamental","pubTime":"2025-10-24 05:18","pubTimestamp":1761254292,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUE13QGTJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMB.AU","BK7067"],"gpt_icon":0},{"id":"2571434689","title":"BRIEF-Cambium Bio Signs MoU With Locus Cell For Manufacturing Of Elate Ocular","url":"https://stock-news.laohu8.com/highlight/detail?id=2571434689","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571434689?lang=en_us&edition=fundamental","pubTime":"2025-09-30 18:25","pubTimestamp":1759227942,"startTime":"0","endTime":"0","summary":"BRIEF-Cambium Bio Signs MoU With Locus Cell For Manufacturing Of Elate OcularSept 30 (Reuters) - Cambium Bio Ltd CMB.AX:SIGNS MOU WITH LOCUS CELL FOR MANUFACTURING OF ELATE OCULARFurther company coverage: CMB.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VG0M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMB.AU","BK7067"],"gpt_icon":0},{"id":"2571394085","title":"Cambium Bio Executes Agreement for Contract Manufacturing of Active Biologic Ingredient for Therapy Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2571394085","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571394085?lang=en_us&edition=fundamental","pubTime":"2025-09-30 12:17","pubTimestamp":1759205825,"startTime":"0","endTime":"0","summary":"Cambium Bio  executed a memorandum of understanding with Taiwan-based Locus Cell for the contract manufacturing of the active biologic ingredient for Elate Ocular, its lead dry eye disease therapy candidate, according to a Tuesday Australian bourse filing.Locus Cell will manufacture the active biologic ingredient, the drug substance component of Elate Ocular, based on pooled fibrinogen-depleted human platelet lysates.Zheng Yang Biomedical Technology, as Cambium's technology partner, will provide manufacturing protocols and conduct technical transfer to Locus Cell. Zheng Yang holds around 28.1% stake in Cambium.The manufacturing rights cover worldwide markets except Europe and the Middle East. Supply will be exclusively to Cambium or its designees under future definitive supply and quality deals. The agreement has a two-year initial term with mutual extension options.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CMB.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CMB.AU\",params:#limit:6,delay:true,,,undefined,":[]}}